Clinical trials: IVF Poor Responders
Ovarian Stimulation
Antagonist/Letrozole in Poor Responders
Failure to respond to controlled ovarian hyperstimulation (COH) is still a major concern in assisted reproduction and there is no consensus on the ovarian stimulation choice regime for poor responders.
- Trial name
- NCT00823004
- Testing
- letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin)
- Where
- Iran
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Yazd Research & Clinical Center for Infertility
Anti-Mullerian Hormone Isoforms
Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders
This study wants to evaluate significant clinical impact of different AMH isoforms in serum can be present or absent in expected poor responder participants.
- Trial name
- NCT03826888
- Where
- United Arab Emirates
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- ART Fertility Clinics LLC
Infertility Assisted Reproductive Technology, Oocyte Retrieval
ART Cycle Outcomes When Only 1 to 3 Oocytes Are Retrieved
This is a monocentric retrospective observational study. The study focuses on the women who underwent Assisted Reproductive Technology (ART) cycles with poor ovarian response (POR), defined as <4 oocytes retrieved.
- Trial name
- POR (NCT06950476)
- Testing
- Oocyte Retrieval
- Volunteers
- 3,761 people, healthy volunteers welcome
- Sponsor
- Istituto Clinico Humanitas